自身免疫性疾病对单侧突发性感音神经性聋预后的影响
回顾性病例对照研究纳入单侧突发性感音神经性聋(SSNHL)合并自身免疫性疾病患者46例,并按性别、年龄、初始纯音平均听阈倾向评分匹配183例无自身免疫病对照。结果显示两组单核细胞与淋巴细胞比值、总胆红素及间接胆红素存在显著差异;发病至治疗时间、单核细胞与淋巴细胞比值及间接胆红素是自身免疫病组独立的预后预测因素。
要点
- 合并自身免疫病的单侧SSNHL患者单核细胞与淋巴细胞比值升高、总胆红素与间接胆红素降低。
- 发病至治疗时间、单核细胞与淋巴细胞比值、间接胆红素与自身免疫病组听力预后独立相关。
- 对合并自身免疫病的单侧SSNHL应关注上述指标以辅助预后判断。
核心结论
- 合并自身免疫性疾病的单侧SSNHL患者单核细胞与淋巴细胞比值升高、总胆红素及间接胆红素降低。
- 发病至治疗时间、单核细胞与淋巴细胞比值及间接胆红素水平与该人群预后密切相关。
研究设计与样本
- 回顾性病例对照研究,单中心三级转诊中心。
- 对照组为按性别、年龄、初始纯音平均听阈倾向评分匹配的无自身免疫病单侧SSNHL住院患者(n=183)。
主要发现
- 两组在单核细胞与淋巴细胞比值、总胆红素及间接胆红素水平上差异显著(P < .05)。
- 单因素分析显示听力预后与发病至治疗时间、最终纯音平均听阈、单核细胞与淋巴细胞比值、间接胆红素及高密度脂蛋白水平显著相关(P < .05)。
- 多因素分析证实发病至治疗时间、单核细胞与淋巴细胞比值及间接胆红素是自身免疫病组的独立预后预测因素。
关键数值与推荐
- 自身免疫病组n=46,对照组n=183。
- 组间单核细胞与淋巴细胞比值、总胆红素、间接胆红素差异P < .05。
- 单因素分析中预后相关因素P < .05。
临床怎么用
- 对合并自身免疫病的单侧SSNHL患者,可结合发病至治疗时间、单核细胞与淋巴细胞比值及间接胆红素评估预后。
- 关注单核细胞与淋巴细胞比值升高及总胆红素、间接胆红素降低的临床意义。
局限性
- 为单中心回顾性研究,样本量有限。
- 采用倾向评分匹配控制混杂,仍可能存在未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate clinical features of unilateral sudden sensorineural hearing loss (SSNHL) in patients with autoimmune disease and identify factors influencing the prognosis of such patients. STUDY DESIGN: Retrospective, case-control study. SETTING: A single tertiary referral center. METHODS: Patients diagnosed with both unilateral SSNHL and autoimmune disease (n = 46) who were hospitalized between January 2018 and October 2023 were included in the autoimmune disease group. A control group propensity score matched for sex, age, and initial pure-tone average (n = 183) comprised hospitalized patients with unilateral SSNHL but without autoimmune disease. The two groups were compared regarding clinical symptoms, audiological evaluations, vestibular function assessments, laboratory blood test results, and hearing outcomes. Prognostic factors were analyzed using binary logistic regression. RESULTS: Autoimmune disease and non-autoimmune disease groups differed significantly in terms of the monocyte-to-lymphocyte ratio, total bilirubin, and indirect bilirubin (P < .05) levels. Univariate analysis identified significant associations between hearing prognosis and the time from disease onset to treatment and final pure-tone average, monocyte-to-lymphocyte ratio, indirect bilirubin, and high-density lipoprotein levels (P < .05). Multivariate analysis further confirmed that time from disease onset to treatment and monocyte-to-lymphocyte ratio and indirect bilirubin levels were independent prognostic predictors in the autoimmune disease group. CONCLUSION: Patients with unilateral SSNHL with autoimmune disease exhibited elevated levels of monocyte-to-lymphocyte ratio and reduced total bilirubin and indirect bilirubin levels as compared with those without autoimmune disease. Time from disease onset to treatment, monocyte-to-lymphocyte ratio, and indirect bilirubin levels were strongly associated with prognosis in this patient population.
引用
- Wang Y, Xiong W, Gao X, et al. Impact of Autoimmune Diseases on the Prognosis of Unilateral Sudden Sensorineural Hearing Loss. Otolaryngol Head Neck Surg. 2026. PMID: 41485240. doi:10.1002/ohn.70104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。